Streetbeat News

Products Services

ELEV

Elevation Oncology, Inc. (NASDAQ:ELEV) experienced a significant stock price increase, closing up 107% at $1.81, following the announcement of program updates and upcoming milestones for 2024. The company plans to update from its Phase 1 trial of EO-3021 in mid-2024 and expand its clinical development program. The stock moved on heavy trading volume, with over 44 million shares traded compared to the 100-day average of less than 476,000 shares.

Portfolio Pulse from Erica Kollmann

January 08, 2024 | 9:16 pm

RKLB

Rocket Lab is scheduled to launch its 'Four of a Kind' mission no earlier than January 18, between 06:15-07:00 UTC. This upcoming event marks a significant milestone for the company as it continues to expand its launch capabilities.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 9:15 pm

EKSO

Ekso Bionics announced the launch of GaitCoach, its next-generation gait therapy software designed for use with EksoNR, the company's robotic exoskeleton.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 9:08 pm

ACN

Accenture has announced the establishment of Generative AI Studios in nine countries across Asia Pacific and Latin America. This move is in response to the increasing interest from clients in generative AI technology.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 9:00 pm

CLNN

Clene Inc. reported positive results from the long-term open label extension of the VISIONARY-MS trial, with improvements in vision and cognition observed in patients treated with CNM-Au8. This news has led to an increase in Clene's stock price.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 8:55 pm

RIO

Rio Tinto (LSE: RIO) is set to initiate the world's largest mining project in Guinea's Simandou mountains, overcoming decades of challenges. The project includes two iron mines, a 400-mile rail system, and a port, with an initial investment of $6.2 billion. Partners include Chalco Iron Ore Holdings and China Baowu Steel Group. The high-grade iron ore from Simandou is crucial for cleaner steelmaking processes, aligning with global climate change goals. Production is expected to start in 2025 with an annual capacity of 60 million tons, Rio Tinto's share being about 27 million tons.

Portfolio Pulse from Stjepan Kalinic

January 08, 2024 | 8:54 pm

MDT

Medtronic plc. (NYSE:MDT) shares are experiencing an uptrend, rising over 2.5% on Monday and approximately 20% over the past two months. The positive momentum follows better-than-expected Q2 results and increased full-year 2024 guidance. Recent FDA approvals for the PulseSelect PFA System and the Percept RC DBS system, along with CE Mark approval for the MiniMed 780G system with Simplera Sync, have contributed to the stock's rise.

Portfolio Pulse from Ryan Gustafson

January 08, 2024 | 8:54 pm

MRNA

Moderna Inc (NASDAQ:MRNA) shares increased after the company presented updates at the JPMorgan Healthcare Conference. Moderna announced progress in its pipeline, with 45 programs and nine in late-stage development. The company is preparing to launch its RSV vaccine and anticipates sales growth in 2025. Moderna reported $6.7 billion in Covid-19 vaccine sales for 2023 and expects $4 billion in sales in 2024. The company has $13 billion in cash and investments and plans to break even in 2026. Upcoming events include financial results on Feb. 22, Vaccines Day on March 27, and R&D Day on Sept. 12. MRNA shares rose 4.19% to $115.76.

Portfolio Pulse from Adam Eckert

January 08, 2024 | 8:53 pm

NKTX

Nkarta, Inc. (NASDAQ:NKTX) stock has surged over 270% in the past month, with an 80.2% increase on the day of reporting. The spike follows an SEC filing where Nkarta updated its corporate presentation with business and strategic updates. The company specializes in developing engineered natural killer (NK) cells for cancer treatment. The trading volume has significantly exceeded the average, with over 41.3 million shares traded compared to the 100-day average of 2.83 million. The stock is also trading above its 50-day moving average, and a high short interest of 17.7% may be contributing to the price movement.

Portfolio Pulse from Erica Kollmann

January 08, 2024 | 8:51 pm

MBLY

Mobileye Global Inc. (NASDAQ:MBLY) shares rose on Monday after announcing production design wins from a major Western automaker for automated driving solutions in 17 vehicle models. The technology will be featured in both internal combustion and electric vehicles, with a rollout expected in 2026. Mobileye's CEO highlighted the milestone in automated driving development. Despite a tough previous week and a sell-off after preliminary 2023 financial results and 2024 guidance, the stock was up 2.95% at $31.39. Raymond James analyst Brian Gesuale maintained an Outperform rating but lowered the price target from $48 to $40.

Portfolio Pulse from Ryan Gustafson

January 08, 2024 | 8:48 pm